Amarin settlement paves way for “off-label” promotion of omega-3 product.
- As previously covered on this blog, the pharmaceutical industry has been awaiting the resolution of the groundbreaking Amarin case.
PHARMACEUTICALS
Fish Oil and the First Amendment
Posted on
Federal court ruling paves the way for off-label promotion of fish oil product.
- FDA’s historical position is that “off-label promotion” — the promotion of pharmaceutical products for unapproved uses —